Citigroup Inc. and its subsidiaries, Citigroup Global Markets Inc., Citigroup Financial Products Inc., and Citigroup Global Markets Holdings Inc., have filed an amended Schedule 13G with the Securities and Exchange Commission on November 12, 2024, indicating a beneficial ownership of 5.7% in Innoviz Technologies Ltd. The filing, which reflects the ownership as of September 30, 2024, shows that the entities collectively possess 9,490,967 ordinary shares of Innoviz Technologies, a company with principal executive offices in Israel. The filing was made under Rule 13d-1(b), indicating that Citigroup and its subsidiaries are not seeking to change or influence the control of Innoviz Technologies but hold the shares in the ordinary course of business. The address for all reporting entities is 388 Greenwich Street, New York, NY 10013, with Citigroup Inc. and Citigroup Financial Products Inc. being Delaware corporations, and the other two entities being New York corporations.

Citigroup Inc. and its subsidiaries, Citigroup Global Markets Inc., Citigroup Financial Products Inc., and Citigroup Global Markets Holdings Inc., have filed an amended Schedule 13G with the Securities and Exchange Commission on November 12, 2024, indicating a beneficial ownership of 5.7% in Innoviz Technologies Ltd. The filing, which reflects the ownership as of September 30, 2024, shows that the entities collectively possess 9,490,967 ordinary shares of Innoviz Technologies, a company with principal executive offices in Israel. The filing was made under Rule 13d-1(b), indicating that Citigroup and its subsidiaries are not seeking to change or influence the control of Innoviz Technologies but hold the shares in the ordinary course of business. The address for all reporting entities is 388 Greenwich Street, New York, NY 10013, with Citigroup Inc. and Citigroup Financial Products Inc. being Delaware corporations, and the other two entities being New York corporations.